Time course comparison of cell-cycle protein expression following partial hepatectomy and WY14,643-induced hepatic cell proliferation in F344 rats

Carcinogenesis

Volumn 18, Issue 5, 1997, Pages 935-941

  Rininger, J A ^a,b   Goldsworthy, T L ^c   Babish, J G ^a,b  

^a Paracelsian Inc   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; HISTONE H1; PHOSPHOTRANSFERASE; PIRINIXIC ACID; PROTEIN P16; PROTEIN P27; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CDC2 PROTEIN KINASE; CDC2-CDC28 KINASES; CELL CYCLE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; CYCLINS; GENES, TUMOR SUPPRESSOR; HEPATECTOMY; LIVER REGENERATION; MALE; MICROBODIES; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PYRIMIDINES; RATS; RATS, INBRED F344; TIME FACTORS;

EID: 0031431372     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.5.935     Document Type: Article

References (61)

1. Pines, J. (1994) The cell cycle kinases. Sem. Cancer Biol., 5, 305-313.
2. Van den Heuvel, S. and Harlow, E. (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science, 262, 2050-2054.
3. Draetta, G. (1994) Mammalian G1 cyclins. Curr. Opin. Cell Biol., 6 842-846.
4. King, R.W., Jackson, P.K. and Kirschner, M.W. (1994) Mitosis in transition Cell, 79, 563-571.
5. Nurse, P. (1994) Ordering S phase and M phase in the cell cycle. Cell, 79, 547-550.
6. Sherr, C.J. (1994) G1 Phase progression; Cycling on cue. Cell, 79, 551-555.
7. Heichman, K.A. and Roberts, J.M. (1994) Rules to replicate by. Cell, 79, 557-562.
8. Hunter, T. and Pines, J. (1994) Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
9. Gong, J., Ardelt, B., Traganos, F. and Darzynkiewicz, Z. (1994) Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res., 54, 4285-4288.
10. Hartwell, L. (1992) Defects in cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71, 543-546.
11. Hirama, T. and Koeffler, H.P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854.
12. Sgambato, A., Han, E.K.-H., Zhang, Y.-J., Moon, R.C., Santella, R.M. and Weinstein, J.B. (1995) Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis, 16, 2193-2198.
13. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704.
14. Serrano, M., Marsman, D.S. and Beach, D. (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 Nature 366, 704-707.
15. Gu, Y., Turck, C.W. and Morgan, D.O. (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature, 366, 707-710.
16. Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J.M., Tempst, P. and Massague, J. (1994) Cloning of p27Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
17. Peter, M. and Herskowitz, I. (1994) Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell, 79, 181-184.
18. Polyak, K., Kato, J.-Y., Solomon, M.I., Sherr, C.J., Massague, J., Roberts, J.M. and Koff, A. (1995) p27Kip1, a cyclin-CDK inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest, Genes Devel., 8, 9-22.
19. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Elledge, S.J. (1993) The p21 CDK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
20. Grana, X. and Reddy, E.P. (1995) Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11, 211-219.
21. Aprelikova, O., Xiong, Y. and Liu, E.T. (1995) Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem., 270, 18195-18197.
22. Lukas, J., Aagaard, L., Strauss, M. and Bartek, J. (1995) Oncogenic aberrations of p16Ink4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res., 55, 4818-4823.
23. Gonzalez-Zulueta, M., Bender, C.M., Yang, A.S., Nguyen, T., Beart, R.W., Van Tornout, J.M. and Jones, P.A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535.
24. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.-P.J., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
25. Reymond, A. and Brent, R. (1995) p16 Proteins from melanoma-prone families are deficient in binding to CDK4. Oncogene, 11, 1173-1178.
26. Okuda, T., Shurtleff, S.A., Valentine, M.B. et al. (1995) Frequent deletion of p16Ink4a/MTS1 and p15Ink4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85, 2321-2330.
27. El-Deiry, W.S., Harper, J.W., O'Conner, P.M. et al. (1994) Waf1/Cip1 is induced in p53 mediated G1 arrest and apoptosis. Cancer Res., 54, 1169-1174.
28. El-Deiry, W.S., Tokino, T., Velculescu, V.E. et al. (1993) Waf1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
29. Steer, C.J. (1995) Liver regeneration. FASEB J., 9, 1396-1400.
30. Loyer, P., Glaise, D., Cariou, S., Baffet, G., Meijer, L. and Guguen-Guillouzo, C. (1994) Expression and activation of CDKs (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J Biol Chem., 269, 2491-2500.
31. Goldsworthy, T.L., Goldsworthy, S.M., Sprankle, C.S. and Butterworth, B.E. (1994) Expression of myc, fos, and Ha-ras Associated with chemically induced cell proliferation in the rat liver. Cell Prolif., 27, 269-278.
32. Busser, M.-T. and Lutz, W.K. (1987) Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters. Carcinogenesis 8 1433-1437.
33. Marsman, D.S., Cattley, R.C., Conway, J.G. and Popp, J.A. (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di-(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]-acetic acid (WY-14,643) in rats. Cancer Res., 48, 6739-6744.
34. Sher, T., Yi, H.-F., McBride, O.W. and Gonzalez, F.J. (1993) cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry, 32, 5598-5604.
35. Poellinger, L., Gottlicher, M. and Gustafsson, J.-A. (1992) The dioxin and peroxisome proliferator-activated receptors in search of endogenous ligands. Trends Pharmacol. Sci., 13, 241-245.
36. Higgins, G.M. and Anderson, R.M. (1931) Experimental pathology of the liver I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol., 12, 136.
37. Towbin, K., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets, procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
38. Albrecht, J.H., Hu, M.Y. and Cerra, F.B. (1995) Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem. Biophys. Res. Commun., 209, 648-655.
39. Castro, A., Jaumot, M., Verges, M., Agell, N. and Bachs, O. (1994) Microsomal localization of cyclin A and CDK2 in proliferating rat liver cells. Biochem. Biophys. Res. Commun., 201, 1072-1078.
40. Dowdy, S.F., Hinds, P.W., Louie, K., Reed, S.I., Arnold, A. and Weinberg, R.A. (1993) Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73, 499-511.
41. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
42. Albrecht, J.H., Hoffman, J.S., Kren, B.S. and Steer, C.J. (1993) Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human disease. Am. J. Physiol., 265, G857-G864.
43. Zindy, F., Lamas, E., Chenivesse, X., Sobczak, J., Wang, J., Fesquet, D., Henglein, B. and Brechot, C. (1992) Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun., 182, 1144-1154.
44. Muerhoff, A.S., Griffin, K.J. and Johnson, E.F. (1992) The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J. Biol. Chem., 267, 19051-19053.
45. Ando, K. and Griffin, J.D. (1995) CDK4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Oncogene, 10, 751-755.
46. Danova, M., Giordano, M., Mazzini, G. and Riccardi, A. (1990) Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leukemia Res., 14, 417-422.
47. Mosner, J. and Deppert, W. (1994) p53 and mdm2 are expressed independently during cellular proliferation. Oncogene, 9, 3321-3328.
48. Deppert, W., Buschhausen-Denker, G., Patschinsky, T. and Steinmeyer, K. (1990) Cell Cycle Control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression. Oncogene, 5, 1701-1706.
49. Shohat, O., Greenberg, M., Reisman, D., Oren, M. and Rotter, V. (1987) Inhibition of cell growth mediated by plasmids encoding p53 anti-sense. Oncogene, 1, 277-283.
50. Rininger, J.A., Wheelock, G.D., Ma, X. and Babish, J.G. (1996) Discordant expression of the cyclin dependent kinases and cyclins in rat liver following acute administration of the hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY14,643). Biochem. Pharmacol., 52, 1749-1755.
51. Bojes, H.K. and Thurman, R.G. (1996) Peroxisome proliferators activate Kupffer cells in vivo. Cancer Res., 56, 1-4.
52. Hengst, L. and Reed, S.I. (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science, 271, 1861-1864.
53. Kamb, A. (1995) Cell cycle regulators and cancer. Trends Genet., 11, 136-140.
54. Kawamata, N., Morosetti, R., Miller, C.W. et al. (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55, 2266-2269.
55. Datto, M.B., Li, Y., Panus, J.F., Howe, D.J., Xiong, Y. and Wang, X.-F. (1995) Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl Acad. Sci. USA, 92, 5545-5549.
56. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A. and El-Houseini, M.E. (1994) Induction of p21 (Waf-1/Cip1) during differentiation. Oncogene, 9, 3389-3396.
57. Yasui, W., Ayhan, A., Kitadai, Y., Nishimura, K., Yokozaki, H., Ito, H. and Tahara, E. (1993) Increased expression of p34cdc2 and its kinase activity in human gastric and colonie carcinomas. Int. J. Cancer, 53, 36-41.
58. Keyomarsi, K. and Pardee, A.B. (1993) Redundent cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl Acad. Sci. USA, 90, 1112-1116.
59. Eyfjord, J.E., Thorlacius, S., Steinarsdottir, M., Valgardsdottir, R., Ogmundsdottir, H.M. and Anamthawat-Jonsson, K. (1995) p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res., 55, 646-651.
60. Wolowiec, D., Deviller, P., Simonin, D., Souchier, C., Rimokh, R., Benchaib, M., Bryon, P.-A. and Ffrench, M. (1995) CDK1 is a marker of proliferation in human lymphoid cells. Int. J. Cancer, 61, 381-388.
61. Steinmann, K.E., Pei, X.F., Stoppler, H. and Schlegel, R. (1994) Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes. Oncogene, 9, 387-394.